What is the commonest site of peptic ulcer?
Which type of surgical suture is known to cause the most tissue reaction?
ESWL is contraindicated in which of the following stones -
Surgery for undescended testis is recommended at what age?
What is the optimal timing for administering antibiotic prophylaxis before surgery?
Which of the following is NOT a feature of membranous urethral injury?
A high-riding prostate is indicative of which injury?
Prostate cancer that is limited to the capsule and not the urethra would be staged as -
A 65 year old male presents with CA prostate. The tumour is limited to the capsule and it is palpable on PR examination. The patient is diagnosed as stage T2a. What is the most appropriate treatment option?
What is the primary treatment for early-stage non-small cell lung cancer?
NEET-PG 2015 - Surgery NEET-PG Practice Questions and MCQs
Question 41: What is the commonest site of peptic ulcer?
- A. Second part of the duodenum
- B. Distal third of the stomach
- C. Pylorus of the stomach
- D. First part of the duodenum (Correct Answer)
Explanation: ***First part of the duodenum*** - The **duodenal bulb** (first part of the duodenum) is the most common location for peptic ulcers due to its proximity to the pylorus, where it's exposed to **acidic chyme** and susceptible to **H. pylori infection**. - The **mucosal defenses** in the duodenum are often less robust compared to the stomach, making it more vulnerable to acid-pepsin aggression. *Second part of the duodenum* - Ulcers in the **second part of the duodenum** are relatively rare compared to the first part. - This section receives bile and pancreatic secretions which help to **neutralize stomach acid**, providing greater protection. *Distal third of the stomach* - Ulcers in the **distal third of the stomach** are less common than in the first part of the duodenum. - While **gastric ulcers** do occur, they are more frequently found in the **antrum or lesser curvature** of the stomach. *Pylorus of the stomach* - Ulcers can occur in the **pylorus**, but they are not as frequent as those in the **duodenal bulb**. - Pyloric ulcers are considered a type of **gastric ulcer** and can be associated with gastric outlet obstruction.
Question 42: Which type of surgical suture is known to cause the most tissue reaction?
- A. Plain Catgut
- B. Polydiaxonone
- C. Silk (Correct Answer)
- D. Chromic catgut
Explanation: ***Silk*** - Silk is a **natural, braided, non-absorbable suture** that is known to elicit a significant **inflammatory reaction** due to its natural protein composition and braided structure. - While it was historically used for its good handling properties, its high tissue reactivity makes it less ideal for situations where minimal scarring or inflammation is desired. - **Silk causes the most tissue reaction** among commonly used sutures. *Plain Catgut* - Plain catgut is a **natural, absorbable suture** derived from purified collagen of animal intestines, causing a moderate to high tissue reaction. - However, its absorption by enzymatic hydrolysis is relatively rapid, limiting the duration of the inflammatory response compared to non-absorbable natural materials like silk. *Polydiaxonone* - Polydiaxonone (PDS) is a **synthetic, monofilament, absorbable suture** known for causing a relatively **low tissue reaction**. - Its slow absorption profile and monofilament structure contribute to its minimal inflammatory response, making it suitable for tissues requiring prolonged support. *Chromic Catgut* - Chromic catgut is a treated form of plain catgut that has been coated with chromium salts, which prolong its absorption time and reduce its tissue reactivity compared to plain catgut. - Although it is still a natural, absorbable suture, its tissue reaction is **less than both plain catgut and silk**, but greater than synthetic monofilament sutures like PDS.
Question 43: ESWL is contraindicated in which of the following stones -
- A. Urate stones
- B. Phosphate stones
- C. Oxalate Stones
- D. Cystine stones (Correct Answer)
Explanation: ***Cysteine stones*** - **Cystine stones** are very dense and hard, making them resistant to fragmentation by the shock waves generated during **Extracorporeal Shock Wave Lithotripsy (ESWL)**. - Due to their resistance to fragmentation, ESWL is generally ineffective for cystine stones, and other treatments like **ureteroscopy** or **percutaneous nephrolithotomy (PCNL)** are often preferred. *Oxalate Stones* - **Calcium oxalate stones** are generally **amenable to ESWL** as they are effectively fragmented by shock waves. - They are the **most common type of kidney stone** and often respond well to lithotripsy. *Urate stones* - **Uric acid stones** are typically **radiolucent** but are often **well-fragmented by ESWL**. - Their non-calcium composition does not hinder the effectiveness of shock waves. *Phosphate stones* - **Struvite (magnesium ammonium phosphate) stones** and **calcium phosphate stones** generally respond well to ESWL. - While sometimes large and branched (**staghorn calculi**), the individual components are susceptible to shock wave fragmentation, though multiple sessions or adjunctive therapies might be needed.
Question 44: Surgery for undescended testis is recommended at what age?
- A. 36 months
- B. 12 months (Correct Answer)
- C. 24 months
- D. 6 months
Explanation: ***12 months*** - **Orchiopexy** for undescended testes is generally recommended around **12 months of age** to optimize fertility and reduce cancer risk. - This timing is within the ideal surgical window of **6-18 months**, balancing the allowance for potential spontaneous descent (which rarely occurs after 6 months) with minimizing germ cell damage. - Most pediatric surgeons prefer operating around **12 months** as it provides optimal outcomes. *6 months* - While **6 months is within the acceptable surgical window** (6-18 months), most surgeons prefer waiting closer to 12 months. - Operating at 6 months is not incorrect, but waiting a few more months allows for logistical planning and ensures any late spontaneous descent has occurred. - The key is to operate **before 18 months** to preserve fertility potential. *24 months* - Delaying surgery until 24 months (2 years) **exceeds the recommended window** and increases the risk of germ cell damage and potential future infertility. - While still beneficial compared to no surgery, the ideal timing for preserving fertility and minimizing malignancy risk has passed. *36 months* - Surgery at 36 months (3 years) is considered a **significant delay** and carries higher risks for long-term complications, including reduced fertility potential and increased risk of testicular cancer. - The benefits of early intervention are largely diminished by this age, though orchiopexy is still indicated to reduce cancer risk and for cosmetic/psychological reasons.
Question 45: What is the optimal timing for administering antibiotic prophylaxis before surgery?
- A. Immediately before induction of anesthesia
- B. 30-60 minutes before incision (Correct Answer)
- C. 2-3 hours before surgery
- D. Immediately after surgery
Explanation: ***30-60 minutes before incision*** - This is the **optimal timing** recommended by WHO, CDC, and major surgical guidelines for most commonly used prophylactic antibiotics (cefazolin, cefuroxime). - Ensures **peak tissue and serum concentrations** are achieved at the time of incision, providing maximum protection against surgical site infections. - Based on **pharmacokinetic principles**: the antibiotic must be present at bactericidal concentrations in tissues when bacterial contamination occurs. - Studies show this timing significantly reduces surgical site infection rates compared to other timings. *Immediately before induction of anesthesia* - While acceptable in some protocols, this may be too early if there is a delay between induction and incision. - Could result in **declining antibiotic levels** by the time the incision is made, especially for antibiotics with shorter half-lives. *2-3 hours before surgery* - This is **too early** for most antibiotics. - Tissue levels may have already **declined below therapeutic concentrations** by the time of incision. - Does not provide adequate protection during the critical period of bacterial contamination. *Immediately after surgery* - This is **treatment, not prophylaxis**. - Offers **no preventive benefit** against intraoperative contamination. - By this time, bacteria introduced during surgery have already adhered to tissues and begun forming biofilms.
Question 46: Which of the following is NOT a feature of membranous urethral injury?
- A. blood at the meatus
- B. Retention of urine
- C. Pelvic fracture
- D. Perineal butterfly hematoma (Correct Answer)
Explanation: ***Perineal butterfly hematoma*** - A **perineal butterfly hematoma** is more characteristic of an injury to the **anterior urethra**, specifically the bulbar urethra, often caused by a straddle injury. - It occurs due to the extravasation of blood into the subcutaneous tissue of the perineum, outlining the shape of a butterfly. *blood at the meatus* - **Blood at the meatus** is a classic sign of urethral injury, regardless of the segment (anterior or posterior). - It indicates disruption of the urethral mucosa and bleeding from the damaged blood vessels. *Retention of urine* - **Retention of urine** can occur due to either a complete or partial urethral transection, preventing normal urine flow. - The inability to void can lead to bladder distension and is a significant symptom in assessing urethral trauma severity. *Pelvic fracture* - **Pelvic fractures** are frequently associated with **membranous urethral injuries** because the membranous urethra is fixed within the pelvic ring. - Shear forces from pelvic trauma can cause the prostatomembranous junction to avulse.
Question 47: A high-riding prostate is indicative of which injury?
- A. Extraperitoneal Bladder rupture
- B. Intraperitoneal Bladder Rupture
- C. Membranous Urethral Injury (Correct Answer)
- D. Bulbar Urethral Injury
Explanation: ***Membranous Urethral Injury*** - A **high-riding prostate** is a classic sign of **membranous urethral injury**, often resulting from **pelvic fractures**. - The disruption of the **urethra** above the perineal membrane causes the prostate to be displaced superiorly and appear "high." *Extraperitoneal Bladder rupture* - This typically occurs with **pelvic fractures** and involves urine leaking into the **retropubic space**. - While associated with pelvic trauma, it does not directly cause a high-riding prostate; the bladder itself may be ruptured, but the relative position of the prostate is not significantly altered. *Intraperitoneal Bladder Rupture* - This type of rupture usually results from a direct blow to a **full bladder** and involves urine extravasating into the **peritoneal cavity**. - It does not cause a high-riding prostate, as the injury is to the dome of the bladder, not the structures supporting the prostate. *Bulbar Urethral Injury* - A **bulbar urethral injury** usually results from a **straddle injury** and is located in the anterior urethra. - This type of injury does not affect the anatomical position of the prostate, which is posterior and superior to the bulbar urethra.
Question 48: Prostate cancer that is limited to the capsule and not the urethra would be staged as -
- A. T1
- B. T2 (Correct Answer)
- C. T3
- D. T0
Explanation: ***T2*** - A T2 stage indicates that the prostate cancer is **confined within the prostate capsule**, meaning it has not spread beyond the outer layer of the prostate gland. - While it is not limited to the urethra, the key defining characteristic of T2 is **capsular confinement**, which is described in the question. *T1* - T1 stage prostate cancer is typically **non-palpable** on digital rectal exam (DRE) and not visible on imaging. - It is often found incidentally, for example, during a **transurethral resection of the prostate (TURP)** for benign prostatic hyperplasia. *T3* - A T3 stage indicates that the prostate cancer has **extended beyond the prostate capsule**, but has not metastasized to distant sites. - This typically involves invasion into the **seminal vesicles** or other periprostatic tissues. *T0* - T0 means there is **no evidence of primary tumor**, which is not consistent with a diagnosed prostate cancer. - This staging is used when there is no measurable tumor.
Question 49: A 65 year old male presents with CA prostate. The tumour is limited to the capsule and it is palpable on PR examination. The patient is diagnosed as stage T2a. What is the most appropriate treatment option?
- A. External beam radiation therapy
- B. Androgen deprivation therapy (ADT)
- C. Active surveillance
- D. Surgical removal of the prostate (Radical prostatectomy) (Correct Answer)
Explanation: ***Surgical removal of the prostate (Radical prostatectomy)*** - **Radical prostatectomy** is the **definitive treatment of choice** for **localized prostate cancer (T2a)** in patients with **good life expectancy (>10 years)**. - For a **65-year-old patient** with tumor confined to the prostate, **surgical removal offers excellent disease control** and potential cure. - This is the **preferred option** when the patient is **medically fit for surgery** and has adequate life expectancy. *External beam radiation therapy* - **External beam radiation therapy (EBRT)** is also an effective treatment for **localized T2a prostate cancer** with comparable long-term survival outcomes. - However, **radical prostatectomy is generally preferred** in younger, healthier patients as it: - Provides definitive pathological staging - Allows for immediate assessment of surgical margins - Preserves radiation as a salvage option if needed - EBRT is better suited for patients who are **not surgical candidates** due to comorbidities or patient preference. *Active surveillance* - **Active surveillance** is appropriate for **very low-risk prostate cancer** (T1c, PSA <10, Gleason ≤6). - For **T2a disease** (palpable tumor), the risk of progression is significant, making active surveillance **not the most appropriate first-line option**. - Would be considered only in patients with limited life expectancy or significant comorbidities. *Androgen deprivation therapy (ADT)* - **ADT** is used for **advanced, locally advanced, or metastatic prostate cancer** to reduce testosterone and slow tumor growth. - It is **not curative** and not appropriate as **monotherapy for localized T2a disease**. - May be used as adjuvant therapy with radiation in higher-risk cases, but not as primary treatment alone.
Question 50: What is the primary treatment for early-stage non-small cell lung cancer?
- A. Radiotherapy
- B. Surgical resection (Correct Answer)
- C. Surgical resection with adjuvant chemotherapy
- D. Immunotherapy
Explanation: ***Surgical resection*** - **Surgical resection** (lobectomy or segmentectomy with lymph node dissection) is the **primary and definitive treatment** for early-stage non-small cell lung cancer (Stage I-II). - For **Stage IA disease**, surgery alone provides excellent outcomes with 5-year survival rates of 70-90%, and adjuvant chemotherapy is generally **not indicated**. - For **Stage IB-II**, surgery remains primary, with adjuvant chemotherapy considered selectively based on tumor size (>4 cm), poor differentiation, vascular invasion, or other high-risk features. - Complete surgical resection offers the **best chance of cure** for resectable early-stage NSCLC. *Surgical resection with adjuvant chemotherapy* - While this combination is important for **select early-stage cases** (high-risk Stage IB, Stage II-IIIA), it is **not the universal primary treatment** for all early-stage disease. - Adjuvant chemotherapy is an **addition** to surgery in specific scenarios, not part of the primary treatment for the majority of early-stage (especially Stage IA) patients. - Current guidelines recommend risk stratification before adding adjuvant therapy. *Radiotherapy* - **Radiotherapy** (stereotactic body radiotherapy/SBRT) is reserved for **medically inoperable** patients or those who refuse surgery. - It is not the primary treatment when the patient is a **surgical candidate**. - May be used as adjuvant therapy in patients with positive margins or N2 disease. *Immunotherapy* - **Immunotherapy** has emerging roles in neoadjuvant/adjuvant settings for resectable NSCLC (recent trials showing benefit). - However, it is **not established as primary monotherapy** for early resectable disease. - More commonly used in advanced/metastatic NSCLC or as part of combination regimens in clinical trial settings for early disease.